123 related articles for article (PubMed ID: 9027594)
1. Relevance of cyclin D1 and other molecular markers to cancer chemoprevention.
Weinstein IB
J Cell Biochem Suppl; 1996; 25():23-8. PubMed ID: 9027594
[TBL] [Abstract][Full Text] [Related]
2. Disorders in cell circuitry associated with multistage carcinogenesis: exploitable targets for cancer prevention and therapy.
Weinstein IB; Begemann M; Zhou P; Han EK; Sgambato A; Doki Y; Arber N; Ciaparrone M; Yamamoto H
Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2696-702. PubMed ID: 10068276
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression.
Jiang W; Kahn SM; Zhou P; Zhang YJ; Cacace AM; Infante AS; Doi S; Santella RM; Weinstein IB
Oncogene; 1993 Dec; 8(12):3447-57. PubMed ID: 8247550
[TBL] [Abstract][Full Text] [Related]
4. Antisense to cyclin D1 inhibits growth and reverses the transformed phenotype of human esophageal cancer cells.
Zhou P; Jiang W; Zhang YJ; Kahn SM; Schieren I; Santella RM; Weinstein IB
Oncogene; 1995 Aug; 11(3):571-80. PubMed ID: 7630641
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of cyclin D1 enhances gene amplification.
Zhou P; Jiang W; Weghorst CM; Weinstein IB
Cancer Res; 1996 Jan; 56(1):36-9. PubMed ID: 8548770
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation.
Lee CC; Yamamoto S; Wanibuchi H; Wada S; Sugimura K; Kishimoto T; Fukushima S
Cancer Res; 1997 Nov; 57(21):4765-76. PubMed ID: 9354438
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of cyclin D1 in mouse skin carcinogenesis.
Bianchi AB; Fischer SM; Robles AI; Rinchik EM; Conti CJ
Oncogene; 1993 May; 8(5):1127-33. PubMed ID: 8479737
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of G1 cyclins and cyclin-dependent kinases during tumor progression of chemically induced mouse skin neoplasms.
Zhang SY; Liu SC; Goodrow T; Morris R; Klein-Szanto AJ
Mol Carcinog; 1997 Mar; 18(3):142-52. PubMed ID: 9115584
[TBL] [Abstract][Full Text] [Related]
9. Antisense oligodeoxynucleotides targeted against different regions of cyclin D1 mRNA may exert different inhibitory effects on cell growth and gene expression.
Hung WC; Huang JS; Chuang LY
Biochem Biophys Res Commun; 1996 Mar; 220(3):719-23. PubMed ID: 8607831
[TBL] [Abstract][Full Text] [Related]
10. Coding sequence of the overexpressed transcript of the putative oncogene PRAD1/cyclin D1 in two primary human tumors.
Rosenberg CL; Motokura T; Kronenberg HM; Arnold A
Oncogene; 1993 Feb; 8(2):519-21. PubMed ID: 8426754
[TBL] [Abstract][Full Text] [Related]
11. Selenium modulation of cell proliferation and cell cycle biomarkers in normal and premalignant cells of the rat mammary gland.
Ip C; Thompson HJ; Ganther HE
Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):49-54. PubMed ID: 10667463
[TBL] [Abstract][Full Text] [Related]
12. Expression of cyclin D1, but not cyclins E and A, is related to progression in bilharzial bladder cancer.
Osman I; Scher H; Zhang ZF; Soos TJ; Hamza R; Eissa S; Khaled H; Koff A; Cordon-Cardo C
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2247-51. PubMed ID: 9815621
[TBL] [Abstract][Full Text] [Related]
13. D-type cyclins in adult human testis and testicular cancer: relation to cell type, proliferation, differentiation, and malignancy.
Bartkova J; Rajpert-de Meyts E; Skakkebaek NE; Bartek J
J Pathol; 1999 Apr; 187(5):573-81. PubMed ID: 10398124
[TBL] [Abstract][Full Text] [Related]
14. Cell cycle basis for the onset and progression of c-Myc-induced, TGFalpha-enhanced mouse mammary gland carcinogenesis.
Liao DJ; Natarajan G; Deming SL; Jamerson MH; Johnson M; Chepko G; Dickson RB
Oncogene; 2000 Mar; 19(10):1307-17. PubMed ID: 10713672
[TBL] [Abstract][Full Text] [Related]
15. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
Ioachim E
Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
[TBL] [Abstract][Full Text] [Related]
16. Cancer risk factors for selecting cohorts for large-scale chemoprevention trials.
Greenwald P
J Cell Biochem Suppl; 1996; 25():29-36. PubMed ID: 9027595
[TBL] [Abstract][Full Text] [Related]
17. Cell cycle regulators in bladder cancer: relationship to schistosomiasis.
Eissa S; Ahmed MI; Said H; Zaghlool A; El-Ahmady O
IUBMB Life; 2004 Sep; 56(9):557-64. PubMed ID: 15590562
[TBL] [Abstract][Full Text] [Related]
18. Infrequent alternations of RB pathway (Rb-p16INK4A-cyclinD1) in adenoid cystic carcinoma of salivary glands.
Shintani S; Mihara M; Nakahara Y; Kiyota A; Yoshihama Y; Ueyama Y; Matsumura T
Anticancer Res; 2000; 20(3B):2169-75. PubMed ID: 10928172
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of cyclin D1 in epithelial ovarian cancers.
Worsley SD; Ponder BA; Davies BR
Gynecol Oncol; 1997 Feb; 64(2):189-95. PubMed ID: 9038263
[TBL] [Abstract][Full Text] [Related]
20. Cyclin alterations in giant cell tumor of bone.
Kauzman A; Li SQ; Bradley G; Bell RS; Wunder JS; Kandel R
Mod Pathol; 2003 Mar; 16(3):210-8. PubMed ID: 12640100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
